What’s new

• Consolidated revenue jumped 32% YoY to ₹86.5 crore.
• Net profit attributable to shareholders rose 52% to ₹9.5 crore.
• Standalone PAT more than doubled to ₹2.7 crore despite flat revenue.

Why it matters

Chembond's strong Q1 performance confirms the growth trajectory in specialty chemicals, with effective cost management boosting margins. For a micro-cap with zero debt and a trailing P/E of 17.4, the earnings beat strengthens its valuation case.

What we’re watching

• Sustainability of volume growth in water treatment and industrial hygiene segments.
• Whether standalone revenue can turn positive in coming quarters.
• Any updates on new product launches or capacity expansion.

The full read

Chembond Chemicals kicked off FY27 with a sharp Q1 beat. Consolidated revenue rose 32% to ₹86.5 crore, while net profit attributable to shareholders surged 52% to ₹9.5 crore (driven by strong volume growth in water treatment and industrial hygiene). On a standalone basis, turnover was flat at ₹18.4 crore, but profit after tax more than doubled to ₹2.7 crore, aided by lower input costs. The results exceed the company's trailing growth rates of 29.9% (revenue) and 33.9% (PAT). For a zero-debt micro-cap with a P/E of 17.4, the earnings momentum reinforces the valuation story. Yet the filing is routine, with no new strategic updates or guidance. The real test now is whether volume growth can sustain through the rest of the year. So far, the trajectory looks strong.

Primary source: BSE · NSE